Total Payments
$8,989
2024 Payments
$1,074
Companies
53
Transactions
486
Medicare Patients
2,998
Medicare Billing
$502,186
Payment Breakdown by Category
Food & Beverage$8,735 (97.2%)
Education$193.78 (2.2%)
Gifts$59.40 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,735 | 481 | 97.2% |
| Education | $193.78 | 4 | 2.2% |
| Gift | $59.40 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,208 | 73 | $0 (2024) |
| Amgen Inc. | $1,108 | 55 | $0 (2024) |
| Lilly USA, LLC | $887.29 | 52 | $0 (2024) |
| Abbott Laboratories | $451.70 | 19 | $0 (2024) |
| Insulet Corporation | $440.68 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $365.47 | 20 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $311.43 | 20 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $309.46 | 18 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $294.68 | 21 | $0 (2024) |
| AbbVie Inc. | $246.79 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,074 | 44 | Lilly USA, LLC ($130.85) |
| 2023 | $1,122 | 55 | Lilly USA, LLC ($150.94) |
| 2022 | $1,188 | 67 | Lilly USA, LLC ($166.80) |
| 2021 | $1,237 | 74 | Novo Nordisk Inc ($230.50) |
| 2020 | $763.14 | 45 | Novo Nordisk Inc ($128.50) |
| 2019 | $1,277 | 63 | Amgen Inc. ($185.39) |
| 2018 | $1,339 | 82 | Novo Nordisk Inc ($229.56) |
| 2017 | $987.38 | 56 | Novo Nordisk Inc ($212.80) |
All Payment Transactions
486 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Obesity | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Durable Pump | ||||||
| 10/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Endocrinology | ||||||
| 10/03/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $20.90 | General |
| 09/24/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $26.07 | General |
| Category: Insulin Pump | ||||||
| 09/24/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $44.84 | General |
| Category: Diabetes Care | ||||||
| 09/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Bone Health | ||||||
| 08/29/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Endocrinology | ||||||
| 08/28/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Endocrinology | ||||||
| 08/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Cardio-renal | ||||||
| 08/22/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $24.49 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/05/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: Automated insulin delivery system | ||||||
| 07/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/16/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Hyperthyroidism | ||||||
| 06/25/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/11/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 701 | 5,053 | $728,208 | $139,063 |
| 2022 | 13 | 757 | 5,021 | $628,263 | $140,577 |
| 2021 | 14 | 723 | 3,887 | $503,643 | $115,592 |
| 2020 | 14 | 817 | 3,677 | $477,523 | $106,954 |
Total Patients
2,998
Total Services
17,638
Medicare Billing
$502,186
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 40 | 4,140 | $460,440 | $76,254 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 389 | $150,442 | $34,794 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $35,238 | $8,528 | 24.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 74 | 77 | $26,554 | $6,246 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 72 | $19,689 | $4,431 | 22.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 22 | $11,887 | $2,888 | 24.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 38 | 63 | $6,672 | $1,666 | 25.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $5,085 | $1,238 | 24.4% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 11 | 11 | $4,520 | $1,189 | 26.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 66 | 103 | $3,502 | $961.52 | 27.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 44 | 74 | $3,482 | $752.85 | 21.6% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 15 | 17 | $697.00 | $114.24 | 16.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 40 | 4,020 | $333,660 | $69,312 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 247 | 408 | $159,312 | $38,694 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $34,983 | $8,374 | 23.9% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 72 | 73 | $27,302 | $6,526 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 89 | $24,312 | $5,904 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 18 | $9,846 | $2,553 | 25.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $7,359 | $1,932 | 26.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $7,119 | $1,714 | 24.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 93 | 148 | $5,032 | $1,419 | 28.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 20 | 20 | $7,000 | $1,371 | 19.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 30 | 47 | $6,016 | $1,277 | 21.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 40 | 74 | $5,402 | $825.47 | 15.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 23 | $920.00 | $676.20 | 73.5% |
About Dr. Geetha Soodini, MD
Dr. Geetha Soodini, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Cumming, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093872558.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Geetha Soodini, MD has received a total of $8,989 in payments from pharmaceutical and medical device companies, with $1,074 received in 2024. These payments were reported across 486 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($8,735).
As a Medicare-enrolled provider, Soodini has provided services to 2,998 Medicare beneficiaries, totaling 17,638 services with total Medicare billing of $502,186. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Cumming, GA
- Active Since 01/03/2007
- Last Updated 02/26/2021
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1093872558
Products in Payments
- Ozempic (Drug) $495.79
- JARDIANCE (Drug) $448.21
- Omnipod (Device) $440.68
- EVENITY (Biological) $416.22
- Repatha (Biological) $315.20
- FARXIGA (Drug) $311.43
- Prolia (Biological) $279.19
- Victoza (Drug) $240.95
- AFREZZA (Drug) $209.55
- MOUNJARO (Drug) $208.99
- Minimed 670G System (Device) $204.00
- BAQSIMI (Drug) $162.85
- SYNTHROID (Drug) $161.32
- Vascepa (Drug) $157.50
- TRULICITY (Drug) $150.77
- HUMULIN (Drug) $148.69
- JANUVIA (Drug) $144.99
- FREESTYLE LIBRE 3 (Device) $141.92
- Korlym (Drug) $140.28
- FreeStyle Lite system (Device) $139.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.